A study found that a blood test detecting ctDNA after surgery more accurately predicts recurrence and survival in patients with stage 3 colon cancer.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company and research collaborators at Mayo Clinic and the Alliance for Clinical Trials in Oncology today announced publication of the ...

Rising CRC incidence and survivorship demand more personalized follow-up care models to alleviate health care system strain. Patients are open to alternative follow-up methods, valuing remote ...

Recurrence risk for stage II to III colon cancer falls below 0.5% 6 years posttreatment, suggesting a potential cure definition. The study analyzed data from 15 phase 3 trials, involving 35,213 ...

Paige Seifert, 25 from Colorado, US, dismissed blood in her stool as hemorrhoids for months before a colonoscopy revealed stage three colon cancer. After surgery to remove the tumor and part of her ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Patients with IBD had an increased risk for venous ...

Colon cancer symptoms often don't exist. An active woman shares how repeated nudges from a loved one led to her diagnosis: "My entire life changed that day." ...

A new report found that colorectal cancer causes more deaths than any other type of cancer, including breast and lung cancers. Experts explain why, and what it means for you.

Paige Seifert, 25 from Colorado, US, dismissed blood in her stool as hemorrhoids for months before a colonoscopy revealed stage three colon cancer. After surgery to remove the tumor and part of her ...